IQVIA Holdings Inc. has disclosed a transaction involving deferred shares by board member John G. Danhakl. This filing, dated November 9, 2026, is significant as it demonstrates the company's ongoing executive activity and its approach to incentivizing leadership.
IQVIA Holdings Inc., identified by the Central Index Key 0001478242, operates in the commercial physical and biological research sector, classified under SIC 8731. The company is publicly traded on the NYSE under the ticker symbol IQV. It has a history of adapting to the evolving landscape of the healthcare and research industries, which is reflected in its recent filings.
According to the recent filing, Danhakl acquired 134 deferred shares on November 5, 2026, at a price of $264.88 per share. Following this transaction, he now owns a total of 3,423 shares in the company. The deferred shares are convertible into common stock upon certain conditions, including the cessation of his role as a director or a change in control of the company.
This transaction may affect the company's governance and its strategic direction, as it reflects the commitment of its directors to the long-term success of IQVIA. The move aligns with industry practices aimed at retaining top talent in a competitive market.
As for what's next, the filing does not specify any further actions or upcoming events related to this transaction.
Read Next
Clark Kyle Sells 15,000 Shares of Beta Technologies Stock
Ronald R. Taylor resigns as director of ResMed Inc.
Afsari Nasym acquires 68,235 shares of Onterris, Inc.
Onterris, Inc. Chief Strategy Officer Acquires Shares
StubHub Holdings' Mark Streams Sells 76,891 Shares
Francesca M. Edwardson Transfers 25,000 Shares to Trust




